Adempas European Union - English - EMA (European Medicines Agency)

adempas

bayer ag - riociguat - hypertension, pulmonary - antihypertensives for pulmonary arterial hypertension - chronic thromboembolic pulmonary hypertension (cteph) adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah) adempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. efficacy has been shown in a pah population including aetiologies of idiopathic or heritable pah or pah associated with connective tissue disease.

Iblias European Union - English - EMA (European Medicines Agency)

iblias

bayer ag - octocog alfa - hemophilia a - antihemorrhagics - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).iblias can be used for all age groups.

Plenadren European Union - English - EMA (European Medicines Agency)

plenadren

takeda pharmaceuticals international ag ireland branch - hydrocortisone - adrenal insufficiency - corticosteroids for systemic use - treatment of adrenal insufficiency in adults.

Ceprotin European Union - English - EMA (European Medicines Agency)

ceprotin

takeda manufacturing austria ag - human protein c - purpura fulminans; protein c deficiency - antithrombotic agents - ceprotin is indicated for prophylaxis and treatment of  purpura fulminans  coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.

Resolor European Union - English - EMA (European Medicines Agency)

resolor

takeda pharmaceuticals international ag ireland - prucalopride succinate - constipation - other drugs for constipation - resolor is indicated for symptomatic treatment of chronic constipation in adults in whom laxatives fail to provide adequate relief.

FERROLOGIC 20 Mg/Ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

ferrologic 20 mg/ml solution for injection

fresenius medical care nephrologica deutschland gmbh - iron sucrose - solution for injection - 20 mg/ml